Latest stories on CTSO
Cytosorbents Advances Toward Operating Cash Flow Breakeven
TipRanks58 · neutralgeneral
Cytosorbents Corp (CTSO) files 8-K
SEC 8-K50 · neutralgeneral
Cytosorbents plans to add 3 to 5 Germany sales reps through early 2027 while targeting second-half 2026 operating cash flow breakeven
Seeking Alpha67 · bullishproduct/pr
Cytosorbents Corporation (CTSO) Q2 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Cytosorbents Non-GAAP EPS of -$0.05, revenue of $9.63M beats by $0.28M
Seeking Alpha56 · neutralearnings
CytoSorbents Reports Second Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
PR Newswire56 · neutralearnings
Cytosorbents Corp (CTSO) files 8-K
SEC 8-K50 · neutralgeneral
CytoSorbents to Report Second Quarter 2026 Financial Results and Recent Business Highlights
PR Newswire50 · neutralgeneral
Cytosorbents Faces Nasdaq Compliance and Delisting Risk
TipRanks28 · bearishgeneral
Cytosorbents Corp (CTSO) files 8-K
SEC 8-K34 · bearishgeneral
Cytosorbents Corporation (CTSO) Presents at Life Sciences Virtual Investor Forum - Slideshow
Seeking Alpha55 · neutralproduct/pr
CytoSorbents Advances FDA Pathway for DrugSorb Programs
TipRanks63 · neutralproduct/pr
Cytosorbents Corp (CTSO) files 8-K
SEC 8-K50 · neutralgeneral
Cytosorbents Corporation 2026 Q1 - Results - Earnings Call Presentation
Seeking Alpha50 · neutralearnings
Transcript: CytoSorbents Q1 2026 Earnings Conference Call
Yahoo Finance55 · neutralearnings
CytoSorbents Reports First Quarter 2026 Financial Results, Recent Business Highlights, and Regulatory Update
PR Newswire50 · neutralearnings